ASK REDCHAT® ANYTHING ABOUT LIGAND PHARMACEUTICALS INC.
Ligand Pharmaceuticals Inc. (NASDAQ: LGND)
Listen to this Section
$118.49
+1.2300
(
+0.48% )
17.9K
Market Data
| Open |
$118.49 |
| Previous Close |
$117.26 |
| Volume |
17.9K |
| Market Cap |
$2.23B |
| Day Range |
$115.50 - $119.57 |
| 52 Week Range |
$67.72 - $129.90 |
| Shares Outstanding |
18.90M |
| Change % |
+0.48% |
| Net Change |
▲ 1.2300 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Biotechnology |
| IPO Year |
1995 |
| Country |
United States |
Analyst Insights
You need to login to view this content.
Insider Ownership Transactions
Total Amount Purchased:
-139,961.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-13 |
Sale |
-18245.00 |
Korenberg Matthew E |
| 2024-08-09 |
Buy |
2500.00 |
Davis Todd C |
| 2024-07-02 |
Sale |
-350.00 |
Korenberg Matthew E |
| 2024-07-02 |
Sale |
-350.00 |
Davis Todd C |
| 2024-07-02 |
Sale |
-329.00 |
Reardon Andrew |
| 2024-07-02 |
Sale |
-267.00 |
Espinoza Octavio |
| 2024-06-25 |
Sale |
-1252.00 |
Sabba Stephen L |
| 2024-06-18 |
Sale |
-1252.00 |
KOZARICH JOHN W |
| 2024-06-18 |
Sale |
-1252.00 |
Gray Nancy Ryan |
| 2024-06-18 |
Sale |
-1252.00 |
Haas Jason |
Institutional Ownership
Total Market Value
$ 0.00
SEC Fillings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
73 |
May 08, 2024 |
| 8-k |
8K-related |
15 |
May 07, 2024 |
| 8-k |
8K-related |
13 |
May 07, 2024 |
| 4 |
Insider transactions |
1 |
May 02, 2024 |
| 4 |
Insider transactions |
1 |
Apr 26, 2024 |
| def |
Proxies and info statements |
24 |
Apr 25, 2024 |
| ars |
Annual reports |
1 |
Apr 25, 2024 |
| 8-k |
8K-related |
14 |
Apr 19, 2024 |
| 4 |
Insider transactions |
1 |
Mar 27, 2024 |
| 4 |
Insider transactions |
1 |
Mar 07, 2024 |